Cerebellar Malformation: Deficits in early neural tube identity found in CHARGE syndrome

  1. Parthiv Haldipur  Is a corresponding author
  2. Kathleen J Millen  Is a corresponding author
  1. Seattle Children’s Research Institute, United States

CHARGE syndrome is a genetic condition that involves multiple malformations in newly born children. The acronym stands for coloboma (a hole in the eye), heart defects, choanal atresia (a blockage of the nasal passage), retarded growth and development, genital abnormalities, and ear anomalies (Lalani et al., 2012). Now, in eLife, Albert Basson of King’s College London (KCL) and co-workers—including Tim Yu of KCL as first author—report that underdevelopment of a region of the cerebellum called the vermis is also associated with CHARGE syndrome (Yu et al., 2013).

Most cases of CHARGE syndrome can be related to a mutation in the gene that encodes CHD7, a protein that is involved in remodelling chromatin (Janssen et al., 2012). The latest work by Yu et al. shows that loss of CHD7 also disrupts the development of the early neural tube, which is the forerunner of the central nervous system. This results in underdevelopment (hypoplasia) of the cerebellar vermis. This finding is extremely exciting as it represents the very first example of this particular class of neural birth defect to be observed in humans.

One of the first steps in the development of the central nervous system is the establishment of gene expression domains that segment the neural tube into the regions that become the forebrain, the midbrain, the hindbrain and the spinal cord. Subsequently, signalling centres establish the boundaries between these regions and secrete growth factors which pattern the adjacent nervous tissue (Kiecker and Lumsden, 2012). The best understood signalling centre is the Isthmic Organizer, which forms at the boundary of the midbrain and the hindbrain. This centre secretes fibroblast growth factor 8 (Fgf8) and other growth factors, and is essential for defining the regions of the neural plate that will become the posterior midbrain and the cerebellum (Figure 1).

The role of the Isthmic Organizer.

The establishment of gene expression domains along the anterior-posterior axis helps to segment the developing brain into the forebrain, midbrain (MB), hindbrain (HB) and spinal cord (SC). Signalling centres established at the boundaries between these segments secrete growth factors which pattern the adjacent nervous tissue. The Isthmic Organizer (IsO; shown in yellow) forms at the boundary of the posterior midbrain and anterior hindbrain: the IsO secretes Fgf8 and other growth factors, and is essential for defining the regions of the neural plate that will become the posterior midbrain (shown in blue) and the cerebellum (CB; green). The homeobox genes Otx2 and Gbx2 are involved in the formation of the IsO and in regulating the expression of Fgf8 by the IsO. Mutations in the CHARGE syndrome gene, CHD7, can alter Otx2, Gbx2 and Fgf8 expression, resulting in underdevelopment of a region of the cerebellum called the vermis (right).

Figure modified from Basson and Wingate, 2013

Extensive experiments in model vertebrates (such as mice, chickens and zebrafish) have shown that if the Isthmic Organizer fails to develop, there is dramatic and rapid cell death in adjacent regions of the neural tube. Mutant mice in which the Isthmic Organizer cannot express Fgf8 at all do not survive post-natally (Chi et al., 2003). However, reduced Fgf8 signalling or a failure to maintain Fgf8 expression does not result in animal death, but rather causes cerebellar vermis hypoplasia (Basson et al., 2008; Sato and Joyner, 2009). The genetic regulatory network that leads to the formation of the Isthmic Organizer is highly conserved across vertebrates, and beyond (Robertshaw and Kiecker, 2012), and it has long been postulated that disruption of the Isthmic Organizer must, therefore, be a cause of human cerebellar malformation. However, until now, this classical developmental phenotype had not been recognized in human patients.

With recent developments in neuroimaging, neuropathology and neurogenetics, many developmental disorders of the cerebellum, including cerebellar vermis hypoplasia, have emerged as causes of neurodevelopmental dysfunction (Doherty et al., 2013). Together, these disorders are relatively common, occurring roughly once in every 3000 live births. Cerebellar malformations can occur in isolation or as part of a broader malformation syndrome involving multiple systems. Although several cerebellar malformation genes have been identified, no gene directly involved in the formation or function of the Isthmic Organizer had previously been implicated in this class of birth defect, suggesting that Isthmic Organizer disorders might not be compatible with survival in humans.

Previously several clinical reports had noted cerebellar deficits in a few CHARGE syndrome patients. Now Yu, Basson and co-workers—who are based in London, Groningen and New York—report the results of MRI scans of a large cohort of 20 patients with CHARGE syndrome (caused by a mutation in CHD7; Yu et al., 2013). They confirm multiple cerebellar abnormalities in 55% of these patients, with 25% of the patients having cerebellar vermis hypoplasia.

Yu et al. also report the results of experiments of mice lacking one or both working copies of the Chd7 gene. Mice lacking one working copy of the gene did not have any obvious cerebellar phenotype, but cerebellar vermis hypoplasia was evident when one copy of the Fgf8 gene was also removed, suggesting genetic synergy between Chd7 and Fgf8. Expression of Fgf8 and its downstream gene Etv5 were significantly down regulated at the junction of the midbrain and the hindbrain during the early development of Chd7 mutant mice. Thus, reduced Fgf8 expression represents an underlying cause of CHARGE-related vermis hypoplasia because cerebellar development is exquisitely sensitive to the level of Fgf8 signalling.

Going one step further, Yu et al. next demonstrated that the expression of two genes that regulate Fgf8 expression at the Isthmic Organizer (Otx2 and Gbx2) is altered in mice lacking both working copies of the Chd7 gene. Chromatin immunoprecipitation assays subsequently revealed that Chd7 is associated with enhancer elements belonging to the Otx2 and Gbx2 genes, which suggests that Chd7 has a direct role in regulating these essential Isthmic Organizer genes.

Together these results provide substantial evidence that cerebellar vermis hypoplasia in CHARGE syndrome is caused by dysfunction of the Isthmic Organizer in the early embryo. Further, the work of Basson, Yu and co-workers suggests that Isthmic Organizer disruption may be a more common cause of human cerebellar malformation than previously thought. Although complete loss-of-function mutations in genes that are central to the formation of the Isthmic Organizer (such as Otx2, Gbx2 and Fgf8) are still likely to be incompatible with human life, this study implies that genes which regulate the expression of central Isthmic Organizer genes may cause cerebellar malformation when mutated.

CHD7 is expressed in a wide variety of tissues during development, and CHARGE syndrome phenotypes indicate that it has tissue-specific and developmental stage-specific roles. A difficult question remains as to how CHD7 achieves different functions in different tissues. For example although loss of Chd7 disrupts Isthmic Organizer Fgf8 expression, Fgf8 expression is normal in the adjacent pharyngeal arches of the embryo. One possibility is that Cdh7 has different binding partners in different tissues.

Intriguingly, it has recently been shown that Cdh7 interacts with a small number of other transcription factors in neural stem cells, and that mutations in these other factors underlie a number of human malformation disorders (Engelen et al., 2011). One exciting prediction of this finding in combination with the work of Yu et al. on CHD7, is that systematic analysis of cerebellar morphology may uncover previously unrecognized cerebellar deficits related to Isthmic Organizer function in a wide range of other human birth defect syndromes.

References

    1. Lalani SR
    2. Hefner MA
    3. Belmont JW
    4. Davenport SLH
    (2012)
    CHARGE Syndrome
    GeneReviews.

Article and author information

Author details

  1. Parthiv Haldipur

    Center for Integrative Brain Research, Seattle Children’s Research Institute, Seattle, United States
    For correspondence
    parthiv.haldipur@seattlechildrens.org
    Competing interests
    The authors declare that no competing interests exist.
  2. Kathleen J Millen

    Center for Integrative Brain Research, Seattle Children’s Research Institute, Seattle, United States
    For correspondence
    kathleen.millen@seattle.childrens.org
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: December 24, 2013 (version 1)

Copyright

© 2013, Haldipur and Millen

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 653
    Page views
  • 79
    Downloads
  • 4
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Parthiv Haldipur
  2. Kathleen J Millen
(2013)
Cerebellar Malformation: Deficits in early neural tube identity found in CHARGE syndrome
eLife 2:e01873.
https://doi.org/10.7554/eLife.01873

Further reading

    1. Developmental Biology
    2. Genetics and Genomics
    Zian Liao, Suni Tang ... Martin Matzuk
    Research Article

    Endometrial decidualization, a prerequisite for successful pregnancies, relies on transcriptional reprogramming driven by progesterone receptor (PR) and bone morphogenetic protein (BMP)-SMAD1/SMAD5 signaling pathways. Despite their critical roles in early pregnancy, how these pathways intersect in reprogramming the endometrium into a receptive state remains unclear. To define how SMAD1 and/or SMAD5 integrate BMP signaling in the uterus during early pregnancy, we generated two novel transgenic mouse lines with affinity tags inserted into the endogenous SMAD1 and SMAD5 loci (Smad1HA/HA and Smad5PA/PA). By profiling the genome-wide distribution of SMAD1, SMAD5, and PR in the mouse uterus, we demonstrated the unique and shared roles of SMAD1 and SMAD5 during the window of implantation. We also showed the presence of a conserved SMAD1, SMAD5, and PR genomic binding signature in the uterus during early pregnancy. To functionally characterize the translational aspects of our findings, we demonstrated that SMAD1/5 knockdown in human endometrial stromal cells suppressed expressions of canonical decidual markers (IGFBP1, PRL, FOXO1) and PR-responsive genes (RORB, KLF15). Here, our studies provide novel tools to study BMP signaling pathways and highlight the fundamental roles of SMAD1/5 in mediating both BMP signaling pathways and the transcriptional response to progesterone (P4) during early pregnancy.

    1. Developmental Biology
    2. Neuroscience
    Tariq Zaman, Daniel Vogt ... Michael R Williams
    Research Article

    The cell-type-specific expression of ligand/receptor and cell-adhesion molecules is a fundamental mechanism through which neurons regulate connectivity. Here, we determine a functional relevance of the long-established mutually exclusive expression of the receptor tyrosine kinase Kit and the trans-membrane protein Kit Ligand by discrete populations of neurons in the mammalian brain. Kit is enriched in molecular layer interneurons (MLIs) of the cerebellar cortex (i.e., stellate and basket cells), while cerebellar Kit Ligand is selectively expressed by a target of their inhibition, Purkinje cells (PCs). By in vivo genetic manipulation spanning embryonic development through adulthood, we demonstrate that PC Kit Ligand and MLI Kit are required for, and capable of driving changes in, the inhibition of PCs. Collectively, these works in mice demonstrate that the Kit Ligand/Kit receptor dyad sustains mammalian central synapse function and suggest a rationale for the affiliation of Kit mutation with neurodevelopmental disorders.